-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Aridis Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from 2017 to 2021.
- Aridis Pharmaceuticals, Inc. Depreciation for the quarter ending September 30, 2022 was $123K, a 32.3% increase year-over-year.
- Aridis Pharmaceuticals, Inc. Depreciation for the twelve months ending September 30, 2022 was $539K, a 51% increase year-over-year.
- Aridis Pharmaceuticals, Inc. annual Depreciation for 2021 was $430K, a 29.5% increase from 2020.
- Aridis Pharmaceuticals, Inc. annual Depreciation for 2020 was $332K, unchanged from 2019.
- Aridis Pharmaceuticals, Inc. annual Depreciation for 2019 was $332K, a 19.4% increase from 2018.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)